About us

Urenco supplies uranium enrichment services and fuel cycle products to customers around the world, helping to provide reliable, low-carbon electricity through nuclear energy.

power cable icon

Our purpose

Enriching the future with
carbon free energy.

world with leaf icon

Our vision

A sustainable net zero world.

hands with nuclear symbol icon

Our mission

Delivering trusted and innovative nuclear services and solutions.

What we do

Nuclear power, alongside renewables, has an important role in the clean energy transition by generating reliable, low-carbon electricity. As a leader in uranium enrichment, Urenco supports this transition by providing a key step in the production of fuel for nuclear power plants.

Our customers typically supply us with natural uranium, which we then process into a form that can be used in nuclear power plants using centrifuge technology designed and deployed by Urenco.

Through the flexible operation of this technology, we are also able to provide other products and services. We are investing in advanced fuel production for the next generation of nuclear reactors, we produce isotope products with medical, industrial and research applications and we have subsidiaries dedicated to responsible nuclear stewardship.

Key facts

supply icon

50+ years

We have a proud history as a leading nuclear services technology company spanning over 50 years.
supply icon

Diversity of supply

We are the only company in the world to operate enrichment facilities in four countries.
person with connectivity icon

50+ customers

We supply uranium enrichment services and fuel cycle products to more than 50 customers in over 20 countries.
SWU icon

17.2m SWU/year

At the end of 2025, our global production capacity was 17.2m SWU/year, with our capacity programme set to increase this.
SWU icon

Advanced fuels

We're developing the advanced fuels needed to support the next generation of nuclear reactors
person with connectivity icon

Isotope innovation

We work with customers to produce isotopes tailored for medical, research and industrial applications.
globe and shield icon

Stewardship expertise

We have two subsidiaries dedicated to overseeing our work in responsible nuclear stewardship.
globe and shield icon

2,700+ employees

We have a highly experienced and dedicated workforce that make these achievements and services possible.

Our global operations

We are unique in the global enrichment market in having facilities in four different countries. These are located in Germany, the Netherlands, the UK and the USA. Our head office is located in London in the UK and we have a USA marketing office in Arlington, Washington.

Our services

With facilities and commercial operations across four countries, our global presence enables us to support customers wherever they operate. Learn about the services we offer across our sites, from reliable uranium enrichment services and fuel cycle solutions to isotope production.

Our technology

We own a 50% interest in Enrichment Technology Company (ETC), a joint venture company with Orano. ETC provides enrichment plant design services and centrifuge technology for Urenco and other enrichers through its subsidiaries in France, Germany, the Netherlands and the UK.

3 people in lab coats talking

Our customers

We supply uranium enrichment services and fuel cycle products to more than 50 customers in over 20 countries. Our global reach and diversity of supply means we are well placed to meet the needs of our customers around the world and we pride ourselves on the quality, flexibility and reliability of our services. We once again met 100% of our customer delivery commitments last year.

Urenco also supplies isotopes to a wide variety of customers across medical, industrial and research industries and we are currently working towards providing advanced fuels to our customers for nuclear new builds, including the next generation of reactors.

Our history

Our history as a leading nuclear technology company spans more than 50 years.


close-up of two people doing calculations

2026 - USA

Urenco announced plans to expand capacity at its Eunice site by nearly 50%, strengthening supply from the United States' only commercial uranium enrichment facility.


close-up of two people doing calculations

2025 - Netherlands

Urenco Isotopes commissioned the Blaise Pascal cascade, expanding stable isotope production capability.


close-up of two people doing calculations

2025 - USA

The US Nuclear Regulatory Commission (NRC) authorised our Eunice site to produce LEU+, making Urenco the first commercial enricher to offer this advanced fuel.


close-up of two people doing calculations

2024 - UK

Urenco announced plans for the UK Advanced Fuels Facility at Capenhurst, supporting the future production of advanced nuclear fuels including HALEU.


close-up of two people doing calculations

2023 - Group

Urenco launched its capacity programme, a long term plan to extend and refurbish enrichment capacity at our sites to meet growing customer demand.

close-up of two people doing calculations

2019 - UK

Urenco opened its Tails Management Facility, responsible for deconverting the by-product of our enrichment services for long-term storage.

close-up of two people doing calculations

2012 - UK

Urenco Nuclear Stewardship began operations, taking responsibility for nuclear materials management, decommissioning and recycling activities at our Capenhurst site.


close-up of two people doing calculations

2010 - USA

Urenco USA began commercial enrichment operations in Eunice, New Mexico, becoming the United States' only commercial uranium enrichment facility.


close-up of two people doing calculations

2005 - Group

The Treaty of Cardiff was signed by the governments of Germany, the Netherlands, France and UK, providing oversight for Urenco's joint venture with Orano, ETC.


close-up of two people doing calculations

2000 - Netherlands

Enrichment facility SP5 began operations at Almelo and now produces more than 90% of Urenco Nederland’s total production capacity.


close-up of two people doing calculations

1992 - USA

The Treaty of Washington was signed by the governments of Germany, the Netherlands, UK and the United States, enabling Urenco's centrifuge technology to be deployed in the USA.


close-up of two people doing calculations

1991 - Netherlands

Urenco began producing stable isotopes for medical, research and industrial applications, creating the foundations of today's Urenco Isotopes business.


close-up of two people doing calculations

1985 - Germany and USA

Urenco Deutschland began production in Gronau, Germany and Urenco opened its US marketing office in Arlington, Washington.


close-up of two people doing calculations

1977 - UK and Netherlands

The world's first commercial-scale demonstration plants at Urenco Nederland and Urenco UK were formally installed.


close-up of two people doing calculations

1975 - UK and Netherlands

Urenco delivered its first SWU contract from pilot plant production at its sites in Capenhurst in the UK and Almelo in the Netherlands.


close-up of two people doing calculations

1970 - Group

Urenco was founded following the signing of the Treaty of Almelo by the governments of Germany, the Netherlands and the United Kingdom, establishing international collaboration on centrifuge enrichment technology.